
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Users of oral steroids are at a reduced risk of developing irritable bowel syndrome”, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
, “The risk of obstructive airways disease in a glaucoma population”, Pharmacoepidemiol Drug Saf, vol. 10, pp. 157-63, 2001.
, “Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism”, Thromb J, vol. 6, p. 10, 2008.
, “Risk of irritable bowel syndrome among asthma patients”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 31-5, 2002.
, “Risk of clinical blood dyscrasia in a cohort of antibiotic users”, Pharmacotherapy, vol. 22, pp. 630-6, 2002.
, “Risk of acute liver injury in patients with diabetes”, Pharmacotherapy, vol. 22, pp. 1091-6, 2002.
, “Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study”, Aliment Pharmacol Ther, vol. 33, pp. 969-78, 2011.
, “Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom”, Arch Intern Med, vol. 167, pp. 935-43, 2007.
, “Respiratory medications and the risk of cardiac arrhythmias”, Epidemiology, vol. 16, pp. 360-6, 2005.
, “Respiratory medications and risk of asthma death”, Thorax, vol. 57, pp. 683-6, 2002.
, “Prevalence of antibiotic use: a comparison across various European health care data sources”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 11-20, 2016.
, ,
“Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population”, Heart, vol. 92, pp. 1610-5, 2006.
, “Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population”, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
, “Lipid-lowering drugs and risk of myopathy: a population-based follow-up study”, Epidemiology, vol. 12, pp. 565-9, 2001.
, “Incidence of ocular melanoma in the general population and in glaucoma patients”, J Epidemiol Community Health, vol. 55, pp. 338-9, 2001.
, “Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study”, Br J Clin Pharmacol, 2019.
, “Incidence and risk factors for psoriasis in the general population”, Arch Dermatol, vol. 143, pp. 1559-65, 2007.
, “Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
, “Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
, “Ascertainment of acute liver injury in two European primary care databases”, Eur J Clin Pharmacol, vol. 70, pp. 1227-35, 2014.
, “Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications”, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
,